nasdaqalgn
Dear fellow investors, A 1930 movie made in the mania toward the end of the Roaring Twenties called Happy Days are Here Again started with this opening stanza: So long sad times Go long bad times We are rid of you at last Howdy gay times Cloudy gray times You are now a thing of the past Q4 2022 hedge fund letters, conferences and more Anyone who has raised children knows that when sins are punished by parents, the last thing those parents want to see is the bad behaviors repeated in the aftermath. This is exactly what the stock market has done so far in the year 2023. The same patterns we saw ...
ValueWalk
After a sub-par performance in 2021, healthcare stocks outperformed the S&P 500 in 2022. As well, 2023 is expected to be another promising year for the healthcare sector. Moreover, healthcare also offers excellent long-term investment opportunities, with U.S. healthcare spending estimated to reach $6.8 trillion by 2030, according to the Centers for Medicare and Medicaid Services. Let’s take a look at the five best and worst performing healthcare stocks in Jan 2023. Five Best Performing Healthcare Stocks In Jan 2023Q4 2022 hedge fund letters, conferences and more Beigene Ltd (NASDAQ:BGNE) share...
ValueWalk
Despite inflation making it hard for the healthcare industry to manage its operating costs, there are a few positives that make this sector attractive to investors. The demand for healthcare is increasing and the healthcare jobs market is improving as well. Both of these factors are expected to help the healthcare industry overcome inflationary pressures. If you are looking to invest in this sector, then to help you select, detailed below are the five best and worst performing healthcare stocks in December 2022. Five Best Performing Healthcare Stocks In December 2022Q4 2022 hedge fund letters,...
ValueWalk
Align Technology, Inc. (NASDAQ:ALGN) was the first company to introduce invisible braces technology for teeth alignment with their Invisalign clear trays.Q4 2021 hedge fund letters, conferences and more For more than two decades, Invisalign became a household name, and globally, orthodontists have treated over 10 million patients for malocclusions with these clear aligners.Invisalign is an expensive tooth straightening treatment and requires regular visits to orthodontists, meaning that as alternatives go mainstream, the company faces headwinds.Despite raising its revenues outlook for 2021 in ...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら